perimenopausal and menopausal Flashcards

1
Q

What is Menopause?

A

DEFINITION:

Aging process  cessation of ovarian estrogen source  cessation of menses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Menopause-Effects estrogen target organs:

A

Ovary, endometrium, vaginal epithelium, vulva, bladder & urethra, uterus, breasts, hepatic metabolism, lipoprotein metabolism, & bone metabolism, cardiovascular system.
Latest research  brain?, colon?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Menopause US Demographics

A

2000:
@ 42.19 million woman over age 50
@ 33.21 million women are over 55.

By 2020  # of women over 55 expected to be 45.2 million.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Age of menopause and onset

A

Average age of menopause  48 – 55
Median age for onset of menopause
transition  47.5

Today  woman who reaches 54 can expect to reach age of 84.3.
Women can expect to live approximately one-third of their lives without ovarian function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Menopause Diagnosis

A

DIAGNOSIS
6 - 12 months of amenorrhea in women over 45.

Elevated levels of FSH & LH → conclusive of ovarian failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Perimenopause

A

25 year continuum from age 35-60 with three distinct phases:
Climacteric.
Menopause
Postmenopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Perimenopause Climacteric Phase

A

(“premenopause” “transitional phase”):
Phase in aging process → woman passes from reproductive to nonreproductive state.

8-10 years prior to onset of menopause:
Menstrual cycle likely to be irregular.
Other climacteric symptoms may occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Perimenopause 2nd phase menopause

A

The final menstruation → terminates reproductive capability.

Diagnosis made only in retrospect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Perimenopause 3rd phase menopause

A

Phase of life after menopause has occurred,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Premature menopause/premature ovarian failure

A

Cessation of menses before age 40.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Surgical menopause

A

Abrupt onset of menopause/menopausal symptoms after removal of ovaries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Menopause “Aging”

A

natural progression of changes in structure & function that occur with the passage of time in the absence of known disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aging of the Menstrual Cycle:

A

Aging of the female reproductive system begins at birth & proceeds as a continuum.
Menopause is a natural biological process  not an estrogen deficiency disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Menopause

Fetal Development

A

6-7 million eggs in a 20 week female fetus; 80% lost by birth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Menopause

Puberty Onset

A

300,000 eggs.

With each menses: for every follicle which ovulates, close to 1000 follicles will pursue abortive growth patterns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Menopause

Age 38-42

A

Number of follicles are decreased & less responsive to FSH  less estrogen is produced.

Decreased estrogen no longer proliferates endometrium to yield menses & menopause occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

menopause

Bleeding Pattern Changes

A

Changes in hormones during climacteric starts onset of menopause transition begins → changes in either frequency, flow or both in a woman who previously experienced regular cycles.

Average woman can expect menstrual irregularity for @ 4 years prior to actual menopause.

10% women experience a perimenopause of less than 6 months duration or sudden amenorrhea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Menopause
Hormones after Menopause
Estrogen

A
Two types:
Estradiol
Secreted by the ovary.  
Major deficiency in menopause.
Estrone	
After menopause  major circulating estrogen.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Menopause

Estrone

A

A less potent estrogen → secreted by ovary before menopause.
After menopause:
Minor source: adrenal gland
Major source: Comes from the conversion of androgens which occurs in fat, muscle, liver, bone marrow, brain, fibroblasts, & hair roots.
Amount of fat tissue is the major determining factor of estrogen levels.
Obesity  creates increased amounts of estrogen.
Puts women at higher risk for endometrial cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Menopause

Progesterone

A

Remains about 30% of follicular phase levels.

Appears to be secreted by the adrenal gland.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Menopause

Testosterone

A

Continues to be secreted by ovary & only minimally lower than premenopausal women.

Two different perspectives:
Coupled with decreased estrogen may partially explain the defeminization, hirsutism & virilism occasionally seen in older women.
Contribute to women’s sex drive, muscle strength, & energy level  improves quality of life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Menopause

Gonadotropins

A

Levels rise → absence of negative feedback system.
Luteinizing Hormone (LH)  3X premenopausal level.
Follicle Stimulating Hormone (FSH)  10-15X premenopausal levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Physiologic Changes of Menopause

A

Estrogen causes the growth of the female reproductive tract → decreased estrogen causes a regression of all reproductive organs.

Changes also occur in estrogen-target organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Menopause

Urogenital Tract

A
Labia Majora & Minora:
Become less prominent.
Vulva skin becomes extremely thin.
Loss of pubic hair. (variable)
Changes make women more prone to vulvar irritation & disease.
25
Q

Menopause

Vagina

A

Shortens & narrows.
Walls thin & dry with ↓ vascularity & elasticity.
Rugae progressively flatten as epithelium thins → capillary bed shines through as diffuse or patchy reddening.
Changes make women more prone to:
“Atrophic Vaginitis” → bacteria easily invade thinning epithelium.
Vaginal bleeding from minimal trauma with douching, sex.
Dyspareunia.

26
Q

menopause

cervix

A

Shrinks & atrophies.

Cervical canal decreases in size.

27
Q

menopause

Uterus

A

Becomes atrophied.
Decreases in size.
Uterine myomas & foci of endometriosis shrink.
Changes make women more prone to:
Increased risk of uterine prolapse due to decreased uterine support.

28
Q

Menopause

Ovaries

A

Begin to decrease in size after age 30 → rate accelerates after age 60.
Becomes atrophic mass of fibrous tissue.
Palpating ovaries on bimanual exam  becomes increasingly difficult.
If ovaries are palpated → must r/o ovarian neoplasm.

29
Q

Menopause

Bladder & Urethra

A

Atrophy causes a change in bladder mucosa & urethral tone.

Changes make women more prone to:
“Atrophic Cystitis” – urinary frequency,
urgency, & incontinence.

30
Q

Menopause

Vasomotor

A

Symptoms:
Hot flashes/flushes.
“flash”– symptoms leading to the “flush”
“power surges” or “hot flashes”?
Night sweats.
Symptoms not life-threatening → can impair the quality of life.

31
Q

Menopause

Hot flashes

A

Most frequent physical complaint:
Affects 80% of all women.
30% classify symptoms as “severe”.

Can happen for a few months up to several years before & after the last menstrual period.

Symptoms last:
1-2 years – most women.
25-50% women - longer then 5 years.

32
Q

Menopause
Hot flashes
symptoms

A

Symptoms:
Sudden onset of reddening of skin over head, neck, & chest.
Feeling of intense body heat.
Sometimes concludes with profuse perspiration.
Appear to be more frequent & more severe at night & at times of stress.

Duration: few seconds  several minutes →
hour+ (rare).

Frequency: rare  recurrent q 10 - 30 minutes

33
Q

Menopause

Etiology of hot flashes

A

Exact cause is unknown  has to do with presence of estrogen & then its withdrawal.

Believed to be related to estrogen deficiency’s effect on hypothalamus.
Area of GnRH neurons as well as thermoregulatory centers.

Recent research  hot flashes may be induced by an imbalance of the endogenous B-endorphins.

34
Q

Menopause
Musculoskeletal
System

A

Symptoms:
Backache.
Osteoporosis.

Reduction in the quantity of bone structure  mechanical fragility  compression and fracture.

35
Q
Effects of 
Osteoporosis
on 
Musculoskeletal
System
Most Common Fx
A

Most common fractures:
Spinal compression fracture:
Vertebral crush fractures (T-8 to L-3)
Most common site of fracture.
Most often occur in 1st decade after menopause.
Decrease in height, dowager’s hump, increased pain.
Average white postmenopausal woman can expect to shrink 2 1/2 inches.

36
Q
Effects of 
Osteoporosis
on 
Musculoskeletal
System Wrist
A

Colles fracture:

Distal forearm & wrist

37
Q
Effects of 
Osteoporosis
on 
Musculoskeletal
System 
Hip
A

Head of femur (hip) fracture:
Most likely to occur later in life → consequence of both aging & long term effects of lower estrogen levels.
20/1000 women age 45 – 85 → 80% associated with osteoporosis.

38
Q
Effects of 
Osteoporosis
on 
Musculoskeletal
System 
Hip
A

With hip fracture → increased morbidity due to complications:
Prior to availability of hip replacement surgery:
Leads to death within 4 months in 12-20% of women.
1/2 of the surviving women need nursing home placement.
Statistics for morbidity improving with advent of total hip replacement.

39
Q

Menopause

Bone Loss

A
Loss of mineral content occurs in all aging individuals, but there are major risk factors:
Age.
Initial bone density.
Menopause
Bioavailability of calcium
Family history.
History of fractures earlier in life.
History of eating disorder.
40
Q

Bone Loss Sporadic risk factors

A
Race ( risk for blacks).
Smoking  risk.
Alcohol use  risk.
Thin stature  risk.
Medical illnesses  risk.
Weight-bearing exercise  risk.
41
Q

Bone Loss Relationship with estrogen

A

Unknown.
Possibly has effect on parathyroid function  parathyroid gland involved in bone synthesis.
Accelerated rate of bone loss after estrogen levels decrease, slows with time, & levels out after approximately 10 years.

Not all postmenopausal women develop osteoporosis  many as-yet undetermined factors may play a role.

42
Q

Menopause

Cardiovascular System and Estrogen

A

Protective effect against CV disease in women.

Incidence of CV events rise rapidly after menopause.

10 years after the ovaries stop producing estrogen
→ incidence of CV disease in women approaches that observed in men.

43
Q

Major deleterious changes in CV system associated with menopause involves alterations in

A

Vasoreactivity – shift from vasodilatation to vasoconstriction.
Coagulation – increased fibrinogen levels & increased platelet aggregation.
Lipid profile
Increased level of low-density (LDL) cholesterol & lipoprotein.
Increased aortic cholesterol accumulation.

44
Q

CV disease facts

A

Single greatest killer of postmenopausal women.
Affects more than 65% of women over age 65.
About 50% of all women will die from CVD.

By the time a woman seeks medical attention, she is usually sicker than her male counterpart.

In spite of this information  women remain less afraid of CVD than breast or uterine cancer.

45
Q

Important Studies - CV disease

A

Heart & Estrogen Replacement Study (HERS)
Postmenopausal women with significant CV disease were given estrogen/progestin HRT  found that HRT did not provide a protective effect for older women.

46
Q

Important Studies CV disease

A

HERSII → part of WHI
Began in fall 1997 → scheduled to be completed in 2005.
Women given estrogen/progestin therapy.
May 2002, study was halted → 26% increase in breast cancer among study group.
Concluded → postmenopausal hormone therapy should not be used for the sole purpose of reducing risk for coronary heart disease in women with CV disease.

47
Q

Menopause

Breast

A

↓ estrogen - symptoms:
Reduced size.
Softer consistency.
Drooping.

48
Q

Menopause

Endocrine System

A

Symptoms:
Decreased estrogen.
Decreased progesterone.
Increased FSH & LH.

49
Q

Menopause

GI System

A

Symptoms:
Decreased BMR.
Easy to gain weight; more difficult to lose it

50
Q

Menopause

Skin & Mucous Membranes

A

Questionable relationship with estrogen deficiency.
Epidermis thins with age in both sexes.
Estrogen may affect water retention in the skin.

51
Q

Menopause

Sexuality

A

Decreased estrogen has 2 effects:
Estrogen-sensitive neuroreceptors located throughout the nervous system.
Decreased estrogen affects nerve impulse transmission  slower response to stimuli.

Decreased estrogen influences peripheral blood flow response to sensory stimulations.
Affects the timing & degree of vasocongestive response during sexual activity.

52
Q

Menopause

General Sexual Problems

A

Delayed or absent vaginal lubrication.
Decreased congestion in the outer third of the vagina.
Fewer & occasionally painful uterine contractions with orgasm.

53
Q

Menopause

Cognitive Functioning

A

Does estrogen plays a major role in the prevention of Alzheimer’s Disease?
Estrogen receptors located throughout the brain.
Hypothesis  estrogen helps support the growth, survival & repair of nerve cells  protecting them from being injured by toxic substances.
Estrogen favorably alters the limbic system which is involved in long-term memory storage & promotes the transmission of brain signals.
Estrogen may also protect against plaque formation in the CNS.

54
Q

Menopause and Alzheimer’s Disease

A

Preliminary studies showed estrogen might be helpful in preventing Alzheimer’s Disease  slowing its rate or progression or improving cognitive functioning in women with the disease.

55
Q

Menopause

WHI Memory Study (WHIMS)

A

Initiated to evaluate the effects of combination HT on cognitive impairment & dementia in postmenopausal women 65 and older.
WHIMS participants received either estrogen alone or estrogen/progestin combination.
Study terminated in 2002 → estrogen-progestin group had twice the incidence of dementia as the placebo group.
Investigators recommended that combination estrogen/progestin therapy not be used to promote cognitive functioning in postmenopausal women.

56
Q

Menopause

Mood

A

Estrogen does influence human female behavior  enhances mood, psychological function, & specific aspects of cognitive function.
Menopause has been associated with psychological problems, particularly depression.
Studies repute this → depression more likely related to social & personal circumstances.

57
Q

“Menopausal Syndrome”

A

Symptoms:
Fatigue, headaches, insomnia, depression, irritability, joint & muscle pain, dizziness, palpitations.
Area not well studied due to the “subjectivity” of complaints.
Symptoms
“domino effect” from the other symptoms of menopause?
Not generally felt to be estrogen related.

58
Q

Developmental Tasks of Menopause:

A

Emancipating adolescent children.
Achieving a peak in one’s career.
Maintaining relationships with aging parents (who may be coming more dependent).
Developing new satisfactions in relationship with spouse.
Developing satisfaction from use of leisure time.
Becoming grandparents.
Preparing for retirement.
Adjusting to physiological aspects of aging.
Husband’s progression through midlife crisis.